1,144
Views
0
CrossRef citations to date
0
Altmetric
Assessment Procedures

Validity and reliability of a new clinician-rated tool for freezing of gait severity

ORCID Icon, , ORCID Icon, , & ORCID Icon
Pages 3133-3140 | Received 12 Jan 2023, Accepted 23 Jul 2023, Published online: 08 Aug 2023

References

  • Global Burden of Disease Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18(5):459–480.
  • Parkinson’s Foundation. Understanding Parkinson’s - Statistics. 2021. https://www.parkinson.org/Understanding-Parkinsons/Statistics
  • Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for parkinson’s disease. Mov Disord. 2015;30(12):1591–1601. doi:10.1002/mds.26424.
  • Ge H-L, Chen X-Y, Lin Y-X, et al. The prevalence of freezing of gait in parkinson’s disease and in patients with different disease durations and severities. Chin Neurosurg J. 2020;6:17. doi:10.1186/s41016-020-00197-y.
  • Zhang W-S, Gao C, Tan Y-Y, et al. Prevalence of freezing of gait in parkinson’s disease: a systematic review and meta-analysis. J Neurol. 2021;268(11):4138–4150. doi:10.1007/s00415-021-10685-5.
  • Nutt JG, Bloem BR, Giladi N, et al. Freezing of gait: moving forward on a mysterious clinical phenomenon. Lancet Neurol. 2011;10(8):734–744. doi:10.1016/S1474-4422(11)70143-0.
  • Hiorth YH, Larsen JP, Lode K, et al. Natural history of falls in a population-based cohort of patients with parkinson’s disease: an 8-year prospective study. Parkinsonism Relat Disord. 2014;20(10):1059–1064. doi:10.1016/j.parkreldis.2014.06.023.
  • Perez-Lloret S, Negre-Pages L, Damier P, et al. Prevalence, determinants, and effect on quality of life of freezing of gait in parkinson disease. JAMA Neurol. 2014;71(7):884–890. doi:10.1001/jamaneurol.2014.753.
  • Tan DM, McGinley JL, Danoudis ME, et al. Freezing of gait and activity limitations in people with parkinson’s disease. Arch Phys Med Rehabil. 2011;92(7):1159–1165. doi:10.1016/j.apmr.2011.02.003.
  • Mancini M, Bloem BR, Horak FB, et al. Clinical and methodological challenges for assessing freezing of gait: future perspectives. Mov Disord. 2019;34(6):783–790. doi:10.1002/mds.27709.
  • D’Cruz N, Seuthe J, De Somer C, et al. Dual task turning in place: a reliable, valid, and responsive outcome measure of freezing of gait. Mov Disord. 2022;37(2):269–278. doi:10.1002/mds.28887.
  • Scully AE, de Oliveira BI, Hill KD, et al. Developing the freezing of gait severity tool: a delphi consensus study to determine the content of a clinician-rated assessment for freezing of gait severity. Clin Rehabil. 2022;36(12):1679–1693. doi:10.1177/02692155221121180.
  • Hulzinga F, Nieuwboer A, Dijkstra BW, et al. The new freezing of gait questionnaire: unsuitable as an outcome in clinical trials? Mov Disord Clin Pract. 2020;7(2):199–205. doi:10.1002/mdc3.12893.
  • Huang S-L, Hsieh C-L, Wu R-M, et al. Minimal detectable change of the timed “up & go” test and the dynamic gait index in people with parkinson disease. Phys Ther. 2011;91(1):114–121. doi:10.2522/ptj.20090126.
  • Saranza G, Lang AE. Levodopa challenge test: indications, protocol, and guide. J Neurol. 2021;268(9):3135–3143. doi:10.1007/s00415-020-09810-7.
  • Barthel C, Mallia E, Debû B, et al. The practicalities of assessing freezing of gait. J Parkinsons Dis. 2016;6(4):667–674. doi:10.3233/JPD-160927.
  • Scully AE, et al. Measurement properties of assessments of freezing of gait severity in people with parkinson disease: a COSMIN review. Phys Therapy. 2021;101(4): p):1–12. doi:10.1093/ptj/pzab009.
  • Crémers J, Phan Ba R, Delvaux V, et al. Construction and validation of the dynamic parkinson gait scale (DYPAGS). Parkinson Related Disord. 2012;18(6):759–764. doi:10.1016/j.parkreldis.2012.03.012.
  • Ziegler K, Schroeteler F, Ceballos-Baumann AO, et al. A new rating instrument to assess festination and freezing gait in parkinsonian patients. Mov Disord. 2010;25(8):1012–1018. doi:10.1002/mds.22993.
  • Mokkink LB, Terwee CB, Stratford PW, et al. Evaluation of the methodological quality of systematic reviews of health status measurement instruments. Qual Life Res. 2009;18(3):313–333. doi:10.1007/s11136-009-9451-9.
  • Podsiadlo D, Richardson S. The timed "up & go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39(2):142–148. doi:10.1111/j.1532-5415.1991.tb01616.x.
  • Kegelmeyer D, et al. Recommendations for patients with Parkinson disease. Parkinson Evidence Database to Guide Effectiveness. 2014. https://www.neuropt.org/docs/default-source/parkinson-edge/recommendations-for-patients.pdf?sfvrsn=890d5543_0
  • Giladi N, Shabtai H, Simon ES, et al. Construction of freezing of gait questionnaire for patients with parkinsonism. Parkinsonism Relat Disord. 2000;6(3):165–170. doi:10.1016/s1353-8020(99)00062-0.
  • Leentjens AFG, Dujardin K, Pontone GM, et al. The parkinson anxiety scale (PAS): development and validation of a new anxiety scale. Mov Disord. 2014;29(8):1035–1043. doi:10.1002/mds.25919.
  • Nasreddine ZS, Phillips NA, Bédirian V, et al. The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–699. doi:10.1111/j.1532-5415.2005.53221.x.
  • Gill DJ, Freshman A, Blender JA, et al. The montreal cognitive assessment as a screening tool for cognitive impairment in parkinson’s disease. Mov Disord. 2008;23(7):1043–1046. doi:10.1002/mds.22017.
  • Goetz CG, Tilley BC, Shaftman SR, et al. Movement disorder society-sponsored revision of the unified parkinson’s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129–2170. doi:10.1002/mds.22340.
  • McKay L, et al. Freezing of gait can persist after an acute levodopa challenge in parkinson’s disease. NPJ Parkinsons Dis. 2019;5:25.
  • Richard IH, Justus AW, Kurlan R. Relationship between mood and motor fluctuations in parkinson’s disease. J Neuropsychiatry Clin Neurosci. 2001;13(1):35–41. doi:10.1176/jnp.13.1.35.
  • Janssen S, Heijs JJA, van der Meijs W, et al. Validation of the auditory stroop task to increase cognitive load in walking tasks in healthy elderly and persons with parkinson’s disease. PLoS One. 2019;14(8):e0220735. doi:10.1371/journal.pone.0220735.
  • Lord SR, Bindels H, Ketheeswaran M, et al. Freezing of gait in people with parkinson’s disease: nature, occurrence, and risk factors. J Parkinsons Dis. 2020;10(2):631–640. doi:10.3233/JPD-191813.
  • Sawada M, Wada-Isoe K, Hanajima R, et al. Clinical features of freezing of gait in parkinson’s disease patients. Brain Behav. 2019;9(4):e01244. doi:10.1002/brb3.1244.
  • Mitchell T, Conradsson D, Paquette C. Gait and trunk kinematics during prolonged turning in parkinson’s disease with freezing of gait. Parkinsonism Relat Disord. 2019;64:188–193. doi:10.1016/j.parkreldis.2019.04.011.
  • O’Day JJ, et al. The turning and barrier course reveals gait parameters for detecting freezing of gait and measuring the efficacy of deep brain stimulation. PLoS One. 2020;15(4):e0231984.
  • Weir JP. Quantifying test-retest reliability using the intraclass correlation coefficient and the SEM. J Strength Cond Res. 2005;19(1):231–240. doi:10.1519/15184.1.
  • de Vet HCW, et al. Measurement in medicine: a practical guide. Cambridge: Cambridge University Press; 2011.
  • Ehgoetz Martens KA, Shine JM, Walton CC, et al. Evidence for subtypes of freezing of gait in parkinson’s disease. Mov Disord. 2018;33(7):1174–1178. doi:10.1002/mds.27417.
  • Mokkink LB, et al. COSMIN study design checklist for patient-reported outcome measurement instruments. Amsterdam: COSMIN; 2019. Available from: https://www.cosmin.nl/wp-content/uploads/COSMIN-study-designing-checklist_final.pdf
  • Moinester M, Gottfried R. Sample size estimation for correlations with pre-specified confidence interval. TQMP. 2014;10(2):124–130. doi:10.20982/tqmp.10.2.p0124.
  • Bonett DG. Sample size requirements for estimating intraclass correlations with desired precision. Stat Med. 2002;21(9):1331–1335. doi:10.1002/sim.1108.
  • Giladi N, Tal J, Azulay T, et al. Validation of the freezing of gait questionnaire in patients with parkinson’s disease. Mov Disord. 2009;24(5):655–661. doi:10.1002/mds.21745.
  • Skorvanek M, Goldman JG, Jahanshahi M, et al. Global scales for cognitive screening in parkinson’s disease: critique and recommendations. Mov Disord. 2018;33(2):208–218. doi:10.1002/mds.27233.
  • Terwee CB, Prinsen CAC, Chiarotto A, et al. COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a delphi study. Qual Life Res. 2018;27(5):1159–1170. doi:10.1007/s11136-018-1829-0.
  • Morris S, Morris ME, Iansek R. Reliability of measurements obtained with the timed “up & go” test in people with parkinson disease. Phys Ther. 2001;81(2):810–818. doi:10.1093/ptj/81.2.810.
  • Ginis P, Nackaerts E, Nieuwboer A, et al. Cueing for people with parkinson’s disease with freezing of gait: a narrative review of the state-of-the-art and novel perspectives. Ann Phys Rehabil Med. 2018;61(6):407–413. doi:10.1016/j.rehab.2017.08.002.
  • Nieuwboer A, Rochester L, Herman T, et al. Reliability of the new freezing of gait questionnaire: agreement between patients with parkinson’s disease and their carers. Gait Posture. 2009;30(4):459–463. doi:10.1016/j.gaitpost.2009.07.108.